Thyrocare promoter releases significant share pledge

Docon Technologies Private Limited, a promoter of Thyrocare Technologies Limited and a wholly-owned subsidiary of API Holdings Limited, announced the release of a pledge on 37,656,092 equity shares of Thyrocare. This represents 71.06% of Thyrocare’s total equity share capital. The shares were previously pledged with Vistra ITCL (India) Limited to secure existing debentures of API Holdings Limited.

The pledge release, effective September 16, 2025, follows API Holdings Limited availing new debt through the issuance of secured, unlisted, redeemable, non-convertible debentures up to INR 1,700 Crore. These proceeds will be used to fully redeem the existing debentures, which had an outstanding nominal value of INR 1,545.38 Crore.

This disclosure was made in compliance with SEBI Regulations, informing stakeholders about the release of these pledged shares. Docon Technologies Private Limited holds 71.06% of Thyrocare’s equity share capital, making this a substantial event for the company.